Entecavir results in early viral load reduction in chronic hepatitis B patients who have failed lamivudine therapy: A randomized, placebo-controlled study in China
单位：[1]Shanghai Jing An Cent Hosp, Shanghai, Peoples R China[2]Shanghai 2 Med Univ, Rui Jin Hosp, Shanghai, Peoples R China[3]Beijing Di Tan Hosp, Beijing, Peoples R China[4]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[5]Chongqing Med Univ, Hosp 2, Chongqing, Peoples R China[6]Bristol Myers Squibb Co, Shanghai, Peoples R China[7]Bristol Myers Squibb Co, Wallingford, CT 06492 USA
Yao G.,Zhou X.,Xu D.,et al.Entecavir results in early viral load reduction in chronic hepatitis B patients who have failed lamivudine therapy: A randomized, placebo-controlled study in China[J].JOURNAL of HEPATOLOGY.2006,44:S193-S193.
APA：
Yao, G.,Zhou, X.,Xu, D.,Wang, B.,Ren, H....&MacDonald, L..(2006).Entecavir results in early viral load reduction in chronic hepatitis B patients who have failed lamivudine therapy: A randomized, placebo-controlled study in China.JOURNAL of HEPATOLOGY,44,
MLA：
Yao, G.,et al."Entecavir results in early viral load reduction in chronic hepatitis B patients who have failed lamivudine therapy: A randomized, placebo-controlled study in China".JOURNAL of HEPATOLOGY 44.(2006):S193-S193
医学